Oral E. coli Vaccine Promising

Article

The August 2000 issue of the journal Infection and Immunity published findings that seem promising for an experimental oral vaccine against pathogenic Escherichia coli. Currently being tested on Israeli military volunteers, the vaccine appears to be safe and to stimulate an appropriate immune response. The study was conducted by researchers from the Israeli Defense Force; Tel Aviv University; Technion-Israel Institute of Technology; University of Negrev; Hebrew University and Hassadah Medical School, Jerusalem; the Walter Reed Army Institute of Research, Washington, DC; and the University of Goteborg, Sweden. For more information visit www.asm.usa.org.

Recent Videos
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Related Content